Authors:
DROVER DR
LEMMENS HJM
NAIDU S
CEVALLOS WH
TROY S
MARTIN PT
STANSKI DR
Citation: Dr. Drover et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER, PHARMACODYNAMIC STUDY OF 10 AND 20 MG DOSES OF ZALEPLON AND ZOLPIDEM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 105-105
Citation: S. Bjorkman et al., APPLICATION OF PHYSIOLOGICAL MODELS TO PREDICT THE INFLUENCE OF CHANGES IN BODY-COMPOSITION AND BLOOD FLOWS ON THE PHARMACOKINETICS OF FENTANYL AND ALFENTANIL IN PATIENTS, Anesthesiology, 88(3), 1998, pp. 657-667
Citation: Cjjg. Bol et al., PHARMACOKINETIC-PHARMACODYNAMIC CHARACTERIZATION OF THE CARDIOVASCULAR, HYPNOTIC, EEG AND VENTILATORY RESPONSES TO DEXMEDETOMIDINE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1051-1058
Authors:
BILLARD V
GAMBUS PL
CHAMOUN N
STANSKI DR
SHAFER SL
Citation: V. Billard et al., A COMPARISON OF SPECTRAL EDGE, DELTA-POWER, AND BISPECTRAL INDEX AS EEG MEASURES OF ALFENTANIL, PROPOFOL, AND MIDAZOLAM DRUG EFFECT, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 45-58
Authors:
WADA DR
BJORKMAN S
EBLING WF
HARASHIMA H
HARAPAT SR
STANSKI DR
Citation: Dr. Wada et al., COMPUTER-SIMULATION OF THE EFFECTS OF ALTERATIONS IN BLOOD FLOWS AND BODY-COMPOSITION ON THIOPENTAL PHARMACOKINETICS IN HUMANS, Anesthesiology, 87(4), 1997, pp. 884-899
Authors:
DOWRIE RH
EBLING WF
MANDEMA JW
STANSKI DR
Citation: Rh. Dowrie et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF PROPOFOL IN HUMAN AND RAT PLASMA AND 14 RAT-TISSUES USING ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 678(2), 1996, pp. 279-288
Authors:
HUNG OR
DYCK JB
VARVEL J
SHAFER SL
STANSKI DR
Citation: Or. Hung et al., COMPARATIVE ABSORPTION KINETICS OF INTRAMUSCULAR MIDAZOLAM AND DIAZEPAM, Canadian journal of anaesthesia, 43(5), 1996, pp. 450-455
Authors:
MANDEMA JW
KAIKO RF
OSHLACK B
REDER RF
STANSKI DR
Citation: Jw. Mandema et al., CHARACTERIZATION AND VALIDATION OF A PHARMACOKINETIC MODEL FOR CONTROLLED-RELEASE OXYCODONE, British journal of clinical pharmacology, 42(6), 1996, pp. 747-756
Citation: Jw. Mandema et Dr. Stanski, POPULATION PHARMACODYNAMIC MODEL FOR KETOROLAC ANALGESIA, Clinical pharmacology and therapeutics, 60(6), 1996, pp. 619-635
Citation: Td. Egan et al., USING THE ELECTROENCEPHALOGRAPHIC (EEG) FINGERPRINT TO DEFINE THE CLINICAL PHARMACODYNAMICS (PD) OF A NOVEL OPIOID - APPLICATION TO REMIFENTANIL (REMI), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 1-1
Citation: Td. Egan et al., THE EEG VERSUS CLINICAL MEASURES OF OPIOID POTENCY - DEFINING THE EEG-CLINICAL POTENCY FINGERPRINT WITH APPLICATION TO REMIFENTANIL, Anesthesiology, 85(3A), 1996, pp. 349-349
Citation: Dr. Wada et al., A PC-BASED GRAPHICAL SIMULATOR FOR PHYSIOLOGICAL PHARMACOKINETIC MODELS, Computer methods and programs in biomedicine, 46(3), 1995, pp. 245-255
Citation: S. Bjorkman et al., COMPARATIVE PHYSIOLOGICAL PHARMACOKINETICS OF FENATYL AND ALFENATIL IN RATS AND HUMANS BASED ON PARAMETRIC SINGLE-TISSUE MODELS (VOL 22, PG387, 1994), Journal of pharmacokinetics and biopharmaceutics, 23(4), 1995, pp. 438-438
Authors:
FISET P
LEMMENS HLM
EGAN TE
SHAFER SL
STANSKI DR
Citation: P. Fiset et al., PHARMACODYNAMIC MODELING OF THE ELECTROENCEPHALOGRAPHIC EFFECTS OF FLUMAZENIL IN HEALTHY-VOLUNTEERS SEDATED WITH MIDAZOLAM, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 567-582
Citation: Dr. Wada et Dr. Stanski, COMPARATIVE PHARMACOKINETICS OF THIOPENTAL, FENTANYL, AND ALFENTANIL IN THE RAT, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 153-153
Authors:
MANDEMA JW
BROWN CR
MROSZCZAK EJ
TSINA IW
STANSKI DR
Citation: Jw. Mandema et al., POPULATION PHARMACODYNAMIC MODEL FOR KETOROLAC ANALGESIA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 188-188
Citation: Hjm. Lemmens et al., PHARMACOKINETIC DYNAMIC ASSESSMENT IN DRUG DEVELOPMENT - APPLICATION TO THE INVESTIGATIONAL OPIOID MIRFENTANIL, Anesthesia and analgesia, 80(6), 1995, pp. 1206-1211
Authors:
PECK CC
BARR WH
BENET LZ
COLLINS J
DESJARDINS RE
FURST DE
HARTER JG
LEVY G
LUDDEN T
RODMAN JH
SANATHANAN L
SCHENTAG JJ
SHAH VP
SHEINER LB
SKELLY JP
STANSKI DR
TEMPLE RJ
VISWANATHAN CT
WEISSINGER J
YACOBI A
Citation: Cc. Peck et al., OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT, Journal of clinical pharmacology, 34(2), 1994, pp. 111-119